SCHEMBL23196338

SCHEMBL23196338

CSc1nc(OC2CC2)ncc1Br

nearest known ligand 0.34

Predicted protein targets (top 6)

geneUniProtsupporting neighboursconfidence
ACACB O00763 1/20 0.34
GAA P10253 1/20 0.33
KHK P50053 1/20 0.32
POLB P06746 1/20 0.31
IKBKB O14920 1/20 0.31
CHUK O15111 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23196350 0.73 GAA (0.62) GAA
SCHEMBL23196336 0.72 ACACB (0.35) ACACBGAAPOLBIKBKB
SCHEMBL29495691 0.71 PKM (0.32)
SCHEMBL22950609 0.71 PKM (0.32)
SCHEMBL18444799 0.69 HMOX1 (0.43) ACACB
SCHEMBL3121668 0.67 PDK2 (0.31)
SCHEMBL26337623 0.67 CDK4 (0.38) ACACB
SCHEMBL3125797 0.66
SCHEMBL1416493 0.66 ABL1 (0.37)
SCHEMBL29397320 0.66 ABL1 (0.37)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4023642-A1 JNK INHIBITOR, AND PHARMACEUTICAL COMPOSITION AND USE THEREOF Wuhan LL Science and Technology Development Co., Ltd. (CN) 2022-07-06 EP disclosed
WO-2021063207-A1 JNK INHIBITOR, AND PHARMACEUTICAL COMPOSITION AND USE THEREOF 武汉朗来科技发展有限公司 2021-04-08 WO disclosed